Jack Sloane
About Jack Sloane
Jack Sloane is a Senior Scientist at Bristol Myers Squibb with a strong background in chemistry and a passion for translational research.
Current Role at Bristol Myers Squibb
Jack Sloane currently holds the position of Senior Scientist at Bristol Myers Squibb. He began his tenure in this role in September 2019, focusing on the application of organic synthesis in the design of novel compounds. His work is instrumental in advancing the pharmaceutical products that the company develops. His strong background in both academic and practical aspects of chemistry supports his contributions to the team.
Academic Background at Stanford University
Jack Sloane pursued his Doctor of Philosophy (PhD) in Chemistry at Stanford University, from 2014 to 2019. During his five-year doctoral studies, he focused on translational research leveraging organic synthesis. His work aimed at developing novel compounds for scientific and medical applications, demonstrating a deep commitment to advancing the field of chemistry through research. This comprehensive academic experience has equipped him with advanced skills and knowledge that are critical in his current role.
Early Academic Experience at Johns Hopkins University
Jack Sloane completed his Bachelor of Arts (B.A.) in Chemistry at The Johns Hopkins University from 2010 to 2014. During this period, he also gained valuable teaching experience as an Organic Chemistry Lab Teaching Assistant (TA) and contributed to research as an Undergraduate Research Assistant. These roles provided him with a solid foundation in both theoretical and practical aspects of organic chemistry.
High School Education
Jack Sloane received his high school diploma from Ethical Culture Fieldston School, where he studied from 2006 to 2010. His early education laid the groundwork for his later academic and professional achievements in the field of chemistry.
Passion for Translational Research
Jack Sloane has a strong passion for translational research, particularly in leveraging organic synthesis to design novel compounds. This passion drives his work in the pharmaceutical industry and underpins his contributions to scientific and medical advancements. His dedication to this area of research highlights his commitment to applying scientific principles to real-world challenges.